PRODUCTS
Indication Index - Hematology Specific Probes
Search for Probes by selecting an Indication
Lymphoma
Diffuse Large B-cell Lymphoma (DLBCL)
Hodgkin Lymphoma
Multiple Myeloma
| 1 | In vitro diagnostic medical device according to EU directive 98/79/EC. CE IVD only available in certain countries. All other countries research use only! Please contact your local dealer for more information. |
Indication Index - Solid Tumor Specific Probes
Search for Probes by selecting an Indication
Cervical Carcinoma
Cervical Carcinoma
Head and Neck Cancer
Oropharyngeal Squamous Cell Cancer (OSCC)
| 1 | In vitro diagnostic medical device according to EU directive 98/79/EC. CE IVD only available in certain countries. All other countries research use only! Please contact your local dealer for more information. |
ZytoFast ® human lg-kappa/lg-lambda Probe
The ZytoFast human Ig-kappa/Ig-lambda Probe (PF22) is intended to be used for the qualitative detection of human Ig-kappa and Ig-lambda light chain mRNA in formalin-fixed, paraffin-embedded specimens, such as multiple myeloma, by chromogenic in situ hybridization (CISH). The probe is intended to be used in combination with the ZytoFast PLUS CISH Implementation Kit HRP-DAB (Prod. No. T 1063-40). The product is intended for professional use only. All tests using the product should be performed in a certified, licensed anatomic pathology laboratory under the supervision of a pathologist/human geneticist by qualified personnel. The probe is intended to be used as an aid to the differential diagnosis of multiple myeloma and therapeutic measures should not be initiated based on the test result alone.
Ordering Information
| Prod. No.: | Tests¹ (Volume): | Registration Status²: | ||
|---|---|---|---|---|
| T-1017-400 |
|
 |
Download Information
| 1 | Using 10 μl probe solution per test. |
| 2 | In vitro diagnostic medical device according to EU directive 98/79/EC. CE IVD only available in certain countries. All other countries research use only! Please contact your local dealer for more information. |
ZytoFast ® human lg-kappa/lg-lambda CISH Kit
The ZytoFast human Ig-kappa/Ig-lambda CISH Kit is intended to be used for the qualitative detection of human Ig-kappa and Ig-lambda light chain mRNA in formalin-fixed, paraffin-embedded specimens, such as multiple myeloma, by chromogenic in situ hybridization (CISH). The product is intended for professional use only. All tests using the product should be performed in a certified, licensed anatomic pathology laboratory under the supervision of a pathologist/human geneticist by qualified personnel. The product is intended to be used as an aid to the differential diagnosis of multiple myeloma and therapeutic measures should not be initiated based on the test result alone.
Ordering Information
| Prod. No.: | Tests¹: | Registration Status²: |
|---|---|---|
| T-1005-40 | 40 | |
Download Information
| |
| 1 | Using 10 μl probe solution per test. |
| 2 | In vitro diagnostic medical device according to EU directive 98/79/EC. CE IVD only available in certain countries. All other countries research use only! Please contact your local dealer for more information. |
ZytoFast ® DNA (+) Control Probe
Ordering Information
| Prod. No.: | Tests¹ (Volume): | Registration Status: | ||
|---|---|---|---|---|
| T-1053-100 |
|
 |
Download Information
| 1 | Using 10 μl probe solution per test. |
